Oliventures, Inc.

Nutritional supplements delivering the benefits of EVOO in one...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Oliventures, Inc.:
Fast Facts

Oliventures makes high-quality, all-natural, polyphenol-rich extra virgin olive and olive fruit extract supplements. We aim to provide health and relief from the daily suffering and pain that Americans face due to chronic inflammation and related diseases.

Chronic inflammation plagues America

28% of Americans have two or more diagnosed chronic diseases — and most of those are caused or exacerbated by chronic inflammation.

Most pharmaceutical companies, physicians and patients focus on the pain or the symptoms, rather than the source of chronic inflammation.

The power of olive fruit polyphenols

Oliventures has performed clinical research and literature searches to understand the power of the active ingredients in olive fruit polyphenols. The common active ingredient in all of our products is olive fruit polyphenols (hydroxytyrsol, tyrosol, and their derviatives) which we have trademarked as TrePhenol®. Oliventure’s “secret sauce” is TrePhenol®; our Spanish Arbequina EVOOs is enriched with TrePhenol® and it is included into each of our target-specific softgel capsules to provide a delicious and convenient way to consume high levels of the EVOO active ingredients – without the unwanted calories and fats.

How It Works

Traction & Accomplishments

Product

  • Acquired the company and began operations in March 2020
  • Rebranded the original “PureVida” product into our OliPura family of products as the flagship product and strengthen the brand
  • Resupplied key inventory

Sales and Manufacturing

  • Online sales and developed specialty wholesale retailers in Florida
  • Key raw material sourced from top tier, high quality suppliers, and four contract manufacturers, all having prior experiences with our products
  • Approximately 50% customer retention rate

Partners
In addition to several contract manufacturing partnerships and raw material supplier partnerships, we have contracts with a leading GI oncologist from Duke University and a leading dietary nutritionist.

Meet The Team

John J. Kaiser, Chairman, Investor, Owner

  • 35 years biopharma experience
  • Commercial/Marketing/Sales, operations, business development, and strategy
  • >$1B pharma deals

David Quigley, President, CEO, Investor, Owner

  • 35 years international and medical device and medtech experience
  • Executive, entrepreneur, operations, finance
  • MBA, MA, Business owner, $16mm financing raised

Loring Cloud, Vice President, Investor, Owner

  • 40+ years biopharma and life science advertising/agency experience
  • Medical liaison and consulting
  • Business owner, Commercial/Marketing/Sales, operations, and strategy

Scott Quigley, Director of Operations and Digital Marketing

  • 10 years nonprofit operations and board experience
  • Digital marketing management, supply chain, operations

Dominique Ostrander, Director Sales SE Region

  • 14 years field sales experience in nutrition supplements in SE Region; Experience selling to specialty retailers, healthcare practitioners, pharmacies and private clinics
  • MS in Exercise Science and Physiology

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.